1 / 9

Bispecific t cell receptor

Bispecific T cell receptor molecules can leverage the body’s immune system by regulating the T-cell response towards cancer cells with specific tumor targets. There are two domains of our bispecific T-cell receptor. <br>https://www.creative-biolabs.com/car-t/bispecific-tcr-development-service.htm

bellasmith123
Download Presentation

Bispecific t cell receptor

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Bispecific T Cell Receptor www.creative-biolabs.com/car-t

  2. Bispecific TCR is a molecule that can regulate the body’s immune system by redirecting and promote the T-cell response towards cancer cells with specific tumor targets.

  3. Background The TCR is a molecule existed on the surface of T cells, or T lymphocytes. Its responsibility is to recognize fragments of antigen to provide peptides bound to major histocompatibility complex (MHC) molecules. The relationship between the binding TCR and antigen peptides is unrestricted and gradually degenerated, which means that TCRs and antigen peptide are not in a biunique relationship. Typically, the TCR is made up of two different protein chains. After being combined with antigenic peptide and MHC (peptide/MHC complex) via TCR, the T lymphocyte will be activated through signal transduction. This is a series of biochemical events mediated by associated enzymes, co-receptors, and specialized adaptor molecules, resulting in activation of transcription factors.

  4. Introduction of Bispecific TCR Bispecific TCR molecules can leverage the body’s immune system by regulating the T-cell response towards cancer cells with specific tumor targets. There are two domains of our bispecific T-cell receptor. One of them is an affinity-maturated and highly selective TCR domain that can recognize and bind to a tumor-specific peptide target presented in the context of HLA class I receptor, the other is a T-cell recruiting antibody domain directed against CD3 or other immuno-modulating T-cell surface proteins. The characteristic of these novel receptors allows T cells to be activated and attack the tumor, regardless of the T cells’ intrinsic specificity. After being administrated to the patients, our bispecific TCR will selectively bind to the surface of targeted tumor cells. Then the bispecific TCR will recruit and activate T cells via CD3 binding initiates tumor killing.

  5. Fig 1. Antigen presentation stimulates T cells with the help of TCR.

  6. Features Ph.D. level scientists and skillful technicians Extensive experience Capable of affinity optimization Low off-target toxicity Superior quality

  7. About • With the exponentially increased demand in modern novel medicine, the CAR and TCR immune cell therapy has been one of the most promising approaches for target-specific cancer treatment. With integrated global resources in all aspects, Creative Biolabs provides one-stop full CAR T/NK Cell therapy development service, including early non-clinical research, process development, pre-clinical animal model testing, cGMP manufacturing, and phase I-III clinical trials.

  8. Contact • 45-1 Ramsey Road, Shirley, NY 11967, USA • Email: marketing@creative-biolabs.com • www.creative-biolabs.com/car-t

  9. ThankYou

More Related